BAY2927088: Clinical Trials

6 trials of BAY2927088, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 available, 1 recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Recruiting 1

Follow BAY2927088: new trials by email Literature Review of BAY2927088 trials Research Report on BAY2927088

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
BAY2927088 - Advanced Solid Tumors, HER2 Mutation
Phase 2RecruitingBayer1112025-02-132026-11-04
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
BAY2927088, Midazolam - Advanced Non-small Cell Lung Cancer, EGFR Mutation
Phase 1CompletedBayer152024-04-172024-07-03
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants
BAY2927088, Itraconazole, Carbamazepine - Advanced Non-small Cell Lung Cancer, EGFR Mutation
Phase 1CompletedBayer302024-04-102024-06-20
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
BAY2927088, Esomeprazole, Food - Advanced Non-small Cell Lung Cancer, EGFR Mutation
Phase 1CompletedBayer212024-03-292024-07-05
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
BAY2927088, Dabigatran etexilate, Rosuvastatin - Advanced Non-small Cell Lung Cancer, EGFR Mutation
Phase 1CompletedBayer152024-03-252024-07-05
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation
Sevabertinib - Advanced Non-small Cell Lung Cancer, Cancer
AvailableBayer2026-07-07

Conditions studied

Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Sponsors

Bayer (6)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)